1. Home
  2. EVGOW vs XGN Comparison

EVGOW vs XGN Comparison

Compare EVGOW & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EVgo Inc.

EVGOW

EVgo Inc.

HOLD

Current Price

$0.01

Market Cap

0.0

ML Signal

HOLD

Logo Exagen Inc.

XGN

Exagen Inc.

HOLD

Current Price

$3.81

Market Cap

71.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVGOW
XGN
Founded
2010
2002
Country
United States
United States
Employees
376
N/A
Industry
Other Specialty Stores
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
71.2M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
EVGOW
XGN
Price
$0.01
$3.81
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$8.86
AVG Volume (30 Days)
154.5K
205.8K
Earning Date
03-07-2025
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$239,306,000.00
N/A
Revenue This Year
N/A
$8.12
Revenue Next Year
N/A
$13.00
P/E Ratio
N/A
N/A
Revenue Growth
73.08
N/A
52 Week Low
$0.00
$2.59
52 Week High
$0.33
$12.23

Technical Indicators

Market Signals
Indicator
EVGOW
XGN
Relative Strength Index (RSI) 39.72 73.74
Support Level $0.00 $2.61
Resistance Level $0.03 $3.89
Average True Range (ATR) 0.01 0.23
MACD 0.00 0.08
Stochastic Oscillator 41.40 93.65

Price Performance

Historical Comparison
EVGOW
XGN

About EVGOW EVgo Inc.

EVgo Inc is an EV fast charging provider. The company deploys charging infrastructure by partnering with retailers, grocery stores, restaurants, gas stations, rideshare operators, and autonomous vehicle companies across the U.S., and serves the EV commercial segment by deploying fleet-charging solutions for light-duty EV fleets at depot locations, off-site charging hubs, or through its public network. It also owns PlugShare, a platform for EV drivers to locate public charging stations, plan trips and share charging experiences, which also provides charging location data licensing, infrastructure analysis, and EV driver research. It also derives revenue from the sale of regulatory credits earned from participation in LCFS programs and other carbon or emissions trading schemes in the U.S.

About XGN Exagen Inc.

Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.

Share on Social Networks: